Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Posaconazole")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 356

  • Page / 15
Export

Selection :

  • and

In vitro activity of posaconazole against clinical isolates of dermatophytesBARCHIESI, Francesco; ARZENI, Daniela; CAMILETTI, Valeria et al.Journal of clinical microbiology (Print). 2001, Vol 39, Num 11, pp 4208-4209, issn 0095-1137Article

Posaconazole : a broad-spectrum triazole antifungalTORRES, Harrys A; HACHEM, Ray Y; CHEMALY, Roy F et al.Lancet. Infectious diseases (print). 2005, Vol 5, Num 12, pp 775-785, issn 1473-3099, 11 p.Article

Pharmacocinétique et pharmacodynamie des antifongiques azolés : exemple du posaconazole = Pharmacokinetics and pharmacodynamics of azole antifungal drugs : the example of posaconazolePADOIN, C; NICOLAS, P; PETITJEAN, O et al.Journal de mycologie médicale (Paris). 2006, Vol 16, issn 1156-5233, S9-S18, SUP1Conference Paper

Effects of Oral Posaconazole on the Pharmacokinetics of Atazanavir Alone and With Ritonavir or With Efavirenz in Healthy Adult VolunteersKRISHNA, Gopal; MOTON, A; MA, L et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 51, Num 4, pp 437-444, issn 1525-4135, 8 p.Article

Refractory coccidioidomycosis treated with posaconazoleANSTEAD, Gregory M; CORCORAN, Gavin; LEWIS, James et al.Clinical infectious diseases. 2005, Vol 40, Num 12, pp 1770-1776, issn 1058-4838, 7 p.Article

Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infectionsHERBRECHT, R.International journal of clinical practice (Esher). 2004, Vol 58, Num 6, pp 612-624, issn 1368-5031, 13 p.Article

Nouveaux antifongiques systémiques = New antifungalsCAZENAVE, B; LANTERNIER, F; LORTHOLARY, O et al.La Lettre de l'infectiologue. 2010, Vol 25, Num 5, pp 178-184, issn 0296-9009, 7 p.Article

New and emerging treatments for fungal infectionsPASQUALOTTO, A. C; DENNING, D. W.Journal of antimicrobial chemotherapy (Print). 2008, Vol 61, issn 0305-7453, i19-i30, SUP1Conference Paper

Intermittent posaconazole regimen to treat superficial Scytalidium dimidiatum infectionDUNAND, Jean; VIGUIE, Claude; PAUGAM, André et al.EJD. European journal of dermatology. 2010, Vol 20, Num 5, pp 649-650, issn 1167-1122, 2 p.Article

Salvage treatment of histoplasmosis with posaconazoleRESTREPO, Angela; TOBON, Angela; GRAYBILL, John R et al.The Journal of infection. 2007, Vol 54, Num 4, pp 319-327, issn 0163-4453, 9 p.Article

Posaconazole is a potent inhibitor of sterol 14α-demethylation in yeasts and moldsMUNAYYER, Hanan K; MANN, Paul A; CHAU, Andrew S et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 10, pp 3690-3696, issn 0066-4804, 7 p.Article

Posaconazole: The Case for Therapeutic Drug MonitoringHOWARD, Susan J; FELTON, Timothy W; GOMEZ-LOPEZ, Alicia et al.Therapeutic drug monitoring. 2012, Vol 34, Num 1, pp 72-76, issn 0163-4356, 5 p.Article

Posaconazole for the treatment of mucormycosisENOCH, D. A; ALIYU, S. H; SULE, O et al.International journal of antimicrobial agents (Print). 2011, Vol 38, Num 6, pp 465-473, issn 0924-8579, 9 p.Article

Quality control limits for posaconazole disk susceptibility tests on mueller-hinton agar with glucose and methylene blueBROWN, S; TRACZEWSKI, M.Journal of clinical microbiology (Print). 2007, Vol 45, Num 1, pp 222-223, issn 0095-1137, 2 p.Article

Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazolePFALLER, M. A; ESPINEL-INGROFF, A; JONES, R. N et al.Journal of clinical microbiology (Print). 2004, Vol 42, Num 10, pp 4577-4580, issn 0095-1137, 4 p.Article

Clinical evaluation of the sensititre YeastOne plate for testing susceptibility of filamentous fungi to posaconazolePATEL, Reena; MENDRICK, Cara; KNAPP, Cindy C et al.Journal of clinical microbiology (Print). 2007, Vol 45, Num 6, pp 2000-2001, issn 0095-1137, 2 p.Article

Disseminated Fusariosis Occurring in Two Patients Despite Posaconazole ProphylaxisBOSE, Prithviraj; PAREKH, Hiral D; HOLTER, Jennifer L et al.Journal of clinical microbiology (Print). 2011, Vol 49, Num 4, pp 1674-1675, issn 0095-1137, 2 p.Article

Effect of Calcineurin Inhibitors on Posaconazole Blood Levels as Measured by the MVista Microbiological AssayZHUANG, David; SMEDEMA, Melinda; LEMONTE, Ann et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 2, pp 730-731, issn 0066-4804, 2 p.Article

Intracellular Concentrations of Posaconazole in Different Compartments of Peripheral BloodFAROWSKI, Fedja; CORNELY, Oliver A; VEHRESCHILD, Jörg J et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 7, pp 2928-2931, issn 0066-4804, 4 p.Article

Pharmacokinetic/Pharmacodynamic Profile of PosaconazoleYANJUN LI; THEURETZBACHER, Ursula; CLANCY, Cornelius J et al.Clinical pharmacokinetics. 2010, Vol 49, Num 6, pp 379-396, issn 0312-5963, 18 p.Article

Therapeutic Drug Monitoring of Posaconazole: a Monocentric Study with 54 AdultsLEBEAUX, David; LANTERNIER, Fanny; ELIE, Caroline et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 12, pp 5224-5229, issn 0066-4804, 6 p.Article

Effect of a nutritional supplement on posaconazole pharmacokinetics following oral administration to healthy volunteersSANSONE-PARSONS, Angela; KRISHNA, Gopal; CALZETTA, Angela et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 5, pp 1881-1883, issn 0066-4804, 3 p.Article

A Reference Laboratory Experience of Clinically Achievable Voriconazole, Posaconazole, and Itraconazole Concentrations within the Bloodstream and Cerebral Spinal FluidWIEDERHOLD, Nathan P; PENNICK, Gennethel J; DORSEY, Sheryl A et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 1, pp 424-431, issn 0066-4804, 8 p.Article

Posaconazole Serum Level on Day 2 Predicts Steady State Posaconazole Serum LevelGREEN, Myke R; WOOLERY, Joseph E.Therapeutic drug monitoring. 2012, Vol 34, Num 1, pp 118-119, issn 0163-4356, 2 p.Article

Posaconazole Serum Concentrations among Cardiothoracic Transplant Recipients: Factors Impacting Trough Levels and Correlation with Clinical Response to TherapySHIELDS, Ryan K; CLANCY, Cornelius J; BERMUDEZ, Christian et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 3, pp 1308-1311, issn 0066-4804, 4 p.Article

  • Page / 15